By infusing behavioral science principles into our technology, we’re able to better engage and retain participants in studies for the long-term. Learn more.
Read moreEyes on the prize: Datacubed releases new Treasure Chest Store
Imagine how an interactive dashboard for study insights could help you monitor and manage your trials. With Datacubed Health, gain access to actionable dashboards to make better, more informed decisions, faster.
Read moreHow does patient engagement Deliver better clinical study insights?
With the proliferation of DCTs, clinical trials are ripe for change. Could this be the catalyst to improve equity and inclusion in clinical studies? We think so.
Read moreHow does the DCT model increase equity in clinical trials?
With DCTs taking the industry by storm, we’ve outlined five “must-haves” to be successful in a decentralized model.
Read moreBetter experience, better results: 5 must-haves for any decentralized trial
We need to keep patients in their trials until they complete the protocol. Too often this mission is lost in the shuffle. This article provides a refresher on the benefits of engagement, and also some best practices to be successful.
How do we want to transform electronic clinical outcome assessments (eCOAs) – including electronic patient-reported outcomes (ePROs) – to drive better patient engagement in the short, mid and long term? There are many possible answers to that question. Let’s explore some together in this article.
Read moreThree ways to transform eCOA – Let’s Frame the Future
Discover how combining behavioral science with innovative technology can improve patient engagement and the success of a CNS study.
Read moreFour Ways to Improve Patient Engagement and Strengthen Data Collection in CNS Trials
Studies show that electronic patient reporting yields higher-quality data than paper-based diaries. As a matter of fact, electronic patient-reported outcomes (ePROs) drive greater participant compliance. With our behavioral science-driven platform, compliance rates are consistently above 90%, and retention rates are above 85% in our client’s clinical trials. For the past decade, both the FDA and …
ENGAGING PATIENTS FOR THE DURATION: THREE WAYS TO IMPROVE RETENTION IN ONCOLOGY STUDIES Oncology trials are among the most complex and expensive when it comes to clinical trials. These trials tend to be lengthy, creating significant participant burdens that result in a higher likelihood of attrition. Moreover, with more protocol deviations than in any other …
Use principles of neuroeconomics to keep clinical trial participants engaged, adherent, and proud of their contributions to curing diseases. Consumer industries have invested millions in improving “customer experience” – how consumers feel or perceive every interaction with a company. The notion of “patient experience” has received comparatively less attention in clinical trials. That’s a missed opportunity. A patient participating …